Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Aseelah Qadmour"'
Autor:
Rand A. Alattar, Shiema Abdalla, Tasneem Abdallah, Rashid Kazman, Aseelah Qadmour, Tawheeda Ibrahim, Bassem Alhariri, Shahd H. Shaar, Abeer Bajwa, Abeir Alimam, Rabia Qazi, Fatma Ben Abid, Joanne Daghfal, Ali Eldeeb, Kinda Shukri, Ahmed Elsayed, Fatima Rustom, Musaed Alsamawi, Alaaeldin Abdelmajid, Miguel A.P. Basulto, Armando A.R. Cobian, Mohamed Abukhattab, Abdullatif Alkhal, Muna A. Almaslamani, Ali S. Omrani
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 10, Pp 1061-1064 (2022)
We retrospectively investigated the clinical outcomes of favipiravir in patients with COVID-19 pneumonia. Patients who between 23 May 2020 and 18 July 2020 received ≥ 24 h of favipiravir were assigned to the favipiravir group, while those who did n
Externí odkaz:
https://doaj.org/article/336874a116ad4e1e96c28f1cefe4923e
Autor:
Fatima Rustom, Rand A. Alattar, Ali M. Eldeeb, Rashid Kazman, Shiema Abdalla, Fatma Ben Abid, Abeir Bh Alimam, Shahd H. Shaar, Ali S. Omrani, Musaed Alsamawi, Aseelah Qadmour, Tasneem A.K. Abdallah, Miguel A. Paulino Basulto, Joanne Daghfal, Alaaeldin Abdelmajid, Abeer Bajwa, Kinda Shukri, Mohamed Abukhattab, Bassem Alhariri, Armando Ar Cobian, Rabia Qazi, Tawheeda B. H. Ibrahim, Muna Almaslamani, Ahmed Elsayed, Abdullatif Al-Khal
BackgroundWe investigated clinical outcomes of favipiravir in patients with COVID-19 pneumonia.MethodsPatients who between 23 May 2020 and 18 July 2020 received ≥24 hours of favipiravir were assigned to the favipiravir group, while those who did no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5f42e2b27b5b559c0e3385482964d02
https://doi.org/10.1101/2021.11.29.21267042
https://doi.org/10.1101/2021.11.29.21267042